CryoLogyx

 

CryoLogyx. Founded by Dr. Tom Congdon and Prof. Matt Gibson, CryoLogyx specializes in developing high-quality cryopreservation solutions for cell-based assays in drug discovery. Here are some key points about CryoLogyx:

  • PlateReady™: Cryopreserved cells directly adhered to microplates, ready for assays within 24 hours post-thaw.

  • CryoShield™: Their patented cryopreservation formulation integrates nature-inspired soluble ice nucleators, controlling ice nucleation and mitigating supercooling effects.

  • CustomReady™: Customized cell-banking service tailored to meet specific research needs, ensuring ready-to-use, high-quality cells.

  • Achievements: CryoLogyx has received awards, including the SLAS Europe New Product Award in 2024.

Discover CryoLogyx’s advanced cryopreservation solutions – simply thaw with cell culture medium, and the cells are ready for use within 24 hours post-thaw. If you have any more questions or need further information, feel free to contact us.

 

Learn more:

  

 

 

 

         

Assay Ready Cryopreservation of Hepatocytes

as 2-D Monolayers

 

           

Meet CryoShield™ : Multi Award-winning

Cryopreservation Solutions

 

            

Meet our latest cryopreserved

 

 

 

 

         
PlaqueReadyTM Models    PlateReady™ Assay-Ready Plates   ToxReady TM Plates
       

 

 

 

Watch the videos :

 

 
 

Thaw and Use Master Class 24 Well Edition

 

       

Thaw and Use Master Class - 96 Well Edition

 

       

How to use CryoLogyx Thaw and Test Assay Cells 

 

         

 

website: www.cryologyx.com

 
Gastrointestinal cancers

Gastrointestinal cancers

Gastrointestinal cancers are a heterogeneous group of diseases that affect the gastrointestinal tract. They can affect various organs, including the oesophagus, stomach, pancreas, liver, gallbladder, small intestine, colon and rectum. Gastrointestinal cancers are caused by a combination of modifiable and non-modifiable risk factors, such as age, sex, diet, smoking, alcohol consumption, obesity, family history and chronic infections.

Each variant of gastrointestinal cancer has unique characteristics, often related to the specific location in the digestive tract.

The molecular biology of gastrointestinal cancers is diverse, involving a range of genetic mutations and epigenetic alterations. These genetic changes can lead to uncontrolled cell proliferation, resistance to apoptosis, and the formation of malignant tumors. Environmental and genetic factors interact in a complex way, contributing to the development of these cancers.

Gastrointestinal cancers present particular challenges because of their heterogeneity and ability to escape the body's normal control mechanisms. Scientific research is focused on gaining an in-depth understanding of the molecular biology underlying these cancers, identifying specific markers and crucial signaling pathways.  Research continues to explore new avenues to better understand the biology of gastrointestinal cancers, paving the way for significant breakthroughs in future prevention and treatment.

Select the cells below to find the most commonly used cell lines complete for each specified cell type.